This trial will study whether the Cereset intervention can help caregivers of newly diagnosed high-grade glioma patients who are under a lot of stress. Cereset is a closed-loop acoustic stimulation intervention that has been studied in people with PTSD, insomnia, postural orthostatic tachycardia, and military veterans.
1 Primary · 6 Secondary · Reporting Duration: 4 months
Awards & Highlights
1 Treatment Group
Intervention with Ambulatory Therapy
1 of 1
24 Total Participants · 1 Treatment Group
Primary Treatment: Cereset Research Wearable · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there still opportunities available to join this experiment?
"Indeed, the information available on clinicaltrials.gov clearly shows that this medical trial is still active and open for recruitment. The initial posting was made on February 1st 2023 with an update occurring later in November 17th 2022. This clinical study requires 24 individuals to be recruited from a single site." - Anonymous Online Contributor
What is the upper limit of individuals participating in this clinical trial?
"Affirmative. According to clinicaltrials.gov, this clinical trial is presently in its recruitment phase and has been since February 1st of 2023 as per the last update on November 17th 2022. A total of 24 patients need to be enrolled from a single medical facility." - Anonymous Online Contributor